Novartis AG
NVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $196,399 | $209,694 | $187,254 | $185,620 |
| - Cash | $11,459 | $13,393 | $7,517 | $12,407 |
| + Debt | $31,258 | $26,348 | $27,909 | $31,025 |
| Enterprise Value | $216,198 | $222,649 | $207,646 | $204,238 |
| Revenue | $51,722 | $46,660 | $43,461 | $43,974 |
| % Growth | 10.8% | 7.4% | -1.2% | – |
| Gross Profit | $38,895 | $34,188 | $31,879 | $32,239 |
| % Margin | 75.2% | 73.3% | 73.4% | 73.3% |
| EBITDA | $20,715 | $18,255 | $14,682 | $30,914 |
| % Margin | 40.1% | 39.1% | 33.8% | 70.3% |
| Net Income | $11,941 | $14,850 | $6,955 | $24,021 |
| % Margin | 23.1% | 31.8% | 16% | 54.6% |
| EPS Diluted | 5.87 | 7.1 | 3.17 | 10.63 |
| % Growth | -17.3% | 124% | -70.2% | – |
| Operating Cash Flow | $17,619 | $14,458 | $14,236 | $15,071 |
| Capital Expenditures | -$3,814 | -$2,753 | -$2,239 | -$2,556 |
| Free Cash Flow | $13,805 | $11,705 | $11,997 | $12,515 |